145

Antonia S. New, Marianne Goodman, Joseph Triebwasser, et al., “Recent Advances in the Biological Study of Personality Disorders,” Psychiatric Clinics of North America 31 (2008): 441–461.

146

Bonnie Jean Steinberg, Robert L. Trestman, and Larry J. Siever, “The Cholinergic and Noradrenergic Neurotransmitter Systems and Affective Instability in Borderline Personality Disorder,” in Biological and Neurobehavioral Studies of Borderline Personality Disorder (Washington, DC: American Psychiatric Publishing, 2005): 41–62.

147

Mary C. Zanarini, Catherine R. Kimble, and Amy A. Williams, “Neurological Dysfunction in Borderline Patients and Axis II Control Subjects,” Biological and Neurobehavioral Studies of Borderline Personality Disorder (Washington, DC: American Psychiatric Publishing, 2005): 159– 175.

148

Jose Manuel de la Funete, Julio Bobes, Coro Vizuete, et al., “Neurologic Soft Signs in Borderline Personality Disorder,” Journal of Clinical Psychiatry 67 (2006): 541–546.

149

Eric Lis, Brian Greenfield, Melissa Henry, et al., “Neuroimaging and Genetics of Borderline Personality Disorder: A Review,” Journal of Psychiatry and Neuroscience 32 (2007): 162–173.

150

American Psychiatric Association, “Practice Guideline for the Treatment of Patients with Borderline Personality Disorder,” American Journal of Psychiatry 158 (2001, October Supplement).

151

Mary C. Zanarini and Frances R. Frankenburg, “Omega-3 Fatty Acid Treatment of Women with Borderline Personality Disorder: A Double-Blind Placebo-

Добавить отзыв
ВСЕ ОТЗЫВЫ О КНИГЕ В ИЗБРАННОЕ

0

Вы можете отметить интересные вам фрагменты текста, которые будут доступны по уникальной ссылке в адресной строке браузера.

Отметить Добавить цитату